This finding emphasizes the importance of in-depth elucidation, and the modulation of the NGF signaling, rather than NGF-blockade, could offer a potential avenue for pain relief and attenuation of neurodegenerative diseases without the bone-related side effects observed in anti-NGF trials. Here, NGF is linked to neurodegenerative disease.